India faces a critical shortage of 41 million blood units annually. Doctors stress that the country needs lifelong donors for ...

Beam reports breakthrough results from BEAM-101's early-stage trial for severe sickle cell disease. Read more here.

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Novo Nordisk has doubled down on position in the sickle cell disease (SCD ... 92% over Forma's closing share price yesterday, but its stock leaped after the deal was announced from $13.40 to ...

The evolutionary link between sickle-cell trait and malaria resistance showed that humans can and do adapt. But are the “bugs” that make us sick evolving as well? While malaria is the best ...

June 3, 2025 — Using a newly devised, three-dimensional model to study the regeneration of nerve tissue in the nose, researchers have discovered that one type of stem cell thought to be dormant ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...

If you want to put money to work in the stock market, you don't necessarily ... producing excellent appreciation over the long run. Image source: Getty Images. If you're looking for some index ...